These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Report of incidence and mortality of gallbladder cancer in China, 2014].
    Author: Tuo JY, Zhang M, Zheng RS, Zhang SW, Li GC, Yang NN, Chen WQ.
    Journal: Zhonghua Zhong Liu Za Zhi; 2018 Dec 23; 40(12):894-899. PubMed ID: 30605978.
    Abstract:
    Objective: The incidence and mortality of gallbladder cancer from Chinese cancer registries in 2014 were analyzed to describe the prevalence of gallbladder cancer in China. Methods: Incidence and mortality data of gallbladder cancer in 2014 derived from registration data in 2017, collected by the National Central Cancer Registry (NCCR). Qualified data from 339 cancer registries were calculated after evaluating. According to the national population data of 2014, the gallbladder cancer incidence and mortality of China in 2014 were stratified by the area, gender and age.The age composition of standard population of Chinese census in 2000 and Segi's population were used for age-standardizes incidence and mortality in China and worldwide. Results: 339 cancer registries cover a total of 288 243 347 population including 146 203 891 males and 142 039 456 females (144 061 915 in urban and 144 181 432 in rural areas). The mortality to incidence ratio of gallbladder cancer was 0.74. The morphologically verified cases (MV%) and death certificate-only cases (DCO%) were 48.38% and 2.66%, respectively. Unclear diagnosis cases (UB%) was 0.48%. The crude incidence of gallbladder cancer in China in 2014 was 3.82/100 000, which accounted for 1.37% of new cancer cases (4.48/100 000 in urban areas and 3.01/100 000 in rural areas, 3.59/100 000 for male and 4.05/100 000 for female). Age-standardized incidence rates by Chinese standard population (ASR China) and world standard population (ASR world) were 2.38/100 000 and 2.37/100 000, respectively, and the cumulative incidence rate (0-74 age years old) was 0.27%.Besides, the crude mortality of gallbladder cancer was 2.86/100 000 (3.47/100 000 in urban areas and 2.12/100 000 in rural areas, 2.59/100 000 for male and 3.14/100 000 for female). Age-standardized mortality rates by ASR China and ASR world were 1.72/100 000 and 1.71/100 000, with a cumulative mortality rate (0-74 age years old) of 0.19%. Conclusion: The incidence and mortality of gallbladder cancer were significantly different between the city and country, while not obviously different between the female and male. 目的： 对全国肿瘤登记地区2014年胆囊癌的发病与死亡情况进行分析，估计全国胆囊癌的发病和死亡情况。 方法： 按照全国肿瘤登记中心制订的审核和评估标准，对全国各登记处上报的2014年肿瘤登记数据进行评估，共339个肿瘤登记处的数据符合标准。将入选的登记处按地区(城乡)、性别、年龄别的发病率和死亡率分层，并结合2014年全国人口数据，估计全国胆囊癌的发病和死亡情况。中国人口标化率(中标率)采用2000年全国人口普查的人口构成，世界人口标化率(世标率)采用Segi′s标准人口构成。 结果： 全国339个肿瘤登记处共计覆盖人口288 243 347人，其中男性146 203 891人，女性142 039 456人；城市144 061 915人，农村144 181 432人。胆囊癌死亡发病比为0.74，病理学诊断比例为48.38%，只有死亡证明书比例为2.66%，诊断依据不明比例为0.48%。2014年中国胆囊癌发病率为3.82/10万，中标发病率为2.38/10万，世标发病率为2.37/10万，累积发病率(0～74岁)为0.27%。城市地区发病率为4.48/10万，农村地区发病率为3.01/10万。男性发病率为3.59/10万，女性发病率为4.05/10万。中国胆囊癌死亡率为2.86/10万，中标死亡率为1.72/10万，世标死亡率为1.71/10万，累积死亡率(0～74岁)为0.19%。城市地区死亡率为3.47/10万，农村地区死亡率为2.12/10万。男性死亡率为2.59/10万，女性死亡率为3.14/10万。 结论： 中国胆囊癌的发病与死亡存在城乡差异，但性别差异不明显。.
    [Abstract] [Full Text] [Related] [New Search]